3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Breast Neoplasms
47
Neoplasm Metastasis
9
Neoplasms
8
Prostatic Neoplasms
7
Brain Neoplasms
7
Endometrial Neoplasms
6
Glioblastoma
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Head and Neck Neoplasms
4
Meningioma
3
Carcinoma, Renal Cell
3
Sarcoma
2
Recurrence
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Oligodendroglioma
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Liposarcoma
2
Hematologic Neoplasms
2
Glioma
2
Breast Neoplasms, Male
2
Breast Diseases
2
Breast Cancer Female
2
Venous Thromboembolism
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Unilateral Breast Neoplasms
1
Interventions
Cyclophosphamide
16
Temozolomide
13
Vincristine
10
Irinotecan
8
Melphalan
7
Doxorubicin
7
Topotecan
6
Granulocyte Colony-Stimulating Factor
6
Busulfan
6
fludarabine
5
cabozantinib
5
Etoposide
5
Drug Therapy
5
liposomal doxorubicin
4
Sirolimus
4
Ifosfamide
4
Filgrastim
4
regorafenib
3
pegfilgrastim
3
irinotecan sucrosofate
3
fludarabine phosphate
3
Zoledronic Acid
3
Radiotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Gemcitabine
3
Cisplatin
3
Bone Marrow Transplantation
3
Albumin-Bound Paclitaxel
3
pegylated granulocyte colony-stimulating factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Sarcoma, Ewing
×
abemaciclib
×
Clear all
NCT02644460
2023-10-26
AflacST1501
Emory University
Phase 1
Completed
53 enrolled